Cargando…

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers

SIMPLE SUMMARY: In recent years there has been a trend towards an increase in the proportion of non-small cell lung cancer patients diagnosed with localized stage instead of advanced. However, 5-year survival rates continue to be low, even among patients diagnosed at early stages. In recent years ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mielgo-Rubio, Xabier, Calvo, Virginia, Luna, Javier, Remon, Jordi, Martín, Margarita, Berraondo, Pedro, Jarabo, José Ramón, Higuera, Oliver, Conde, Esther, De Castro, Javier, Provencio, Mariano, Hernando Trancho, Florentino, López-Ríos, Fernando, Couñago, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699975/ https://www.ncbi.nlm.nih.gov/pubmed/33233705 http://dx.doi.org/10.3390/cancers12113459

Ejemplares similares

Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

AB014. Effective somatostatin analogs in a case of advanced thymoma with no uptake in the octreotide scan
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2022)

Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
por: Sereno, María, et al.
Publicado: (2021)

Thoracic surgery in Spain
por: Varela, Gonzalo, et al.
Publicado: (2022)

When the Need is Greater Than Feasible
por: Fraile Olivero, Carlos Alfredo, et al.
Publicado: (2020)

Spanish Lung Cancer Group SCAT trial: surgical audit to lymph node assessment based on IASLC recommendations
por: Jarabo Sarceda, José Ramón, et al.
Publicado: (2021)

Effect of COVID-19 on Thoracic Oncology Surgery in Spain: A Spanish Thoracic Surgery Society (SECT) Survey
por: Martínez-Hernández, Néstor J., et al.
Publicado: (2021)

Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story
por: Serrano, Javier, et al.
Publicado: (2021)

Tsunami of immunotherapy reaches mesothelioma
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2022)

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Coronavirus disease 2019 and lung cancer: where are we?
por: Ocanto, Abrahams, et al.
Publicado: (2023)

Deep diving in the PACIFIC: Practical issues in stage III non-small cell lung cancer to avoid shipwreck
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

The Use of Fissios App© as a Complement to a Face-to-Face Respiratory Physiotherapy Program versus an Attendance-Only Face-to-Face Physiotherapy Program in Patients Scheduled for Thoracic Surgical Procedures Reduces the Risk of Developing Postoperative Pulmonary Complications—A Quasi-Experimental Study
por: Fraile Olivero, Carlos Alfredo, et al.
Publicado: (2023)

Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022)

High tumor burden in non-small-cell lung cancer: A review of the literature
por: Cabezón-Gutiérrez, Luis, et al.
Publicado: (2022)

Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
por: Aguado, Carlos, et al.
Publicado: (2022)

Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies
por: Martin, Margarita, et al.
Publicado: (2022)

Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
por: Aguado, Carlos, et al.
Publicado: (2022)

Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review
por: Calvo, Virginia, et al.
Publicado: (2021)

Thoracoscopic segmentectomy versus lobectomy: A propensity score–matched analysis
por: Sesma, Julio, et al.
Publicado: (2022)

Immunotherapy in non-small cell lung cancer: Update and new insights
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

Advances and controversies in the management of early stage non-small cell lung cancer
por: Cilleruelo-Ramos, Angel, et al.
Publicado: (2021)

Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review
por: Ortega-Franco, Ana, et al.
Publicado: (2020)

Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Sotelo, Miguel J, et al.
Publicado: (2021)

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2
por: Olmedo, Maria Eugenia, et al.
Publicado: (2022)

Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity
por: Fernández-Marcelo, Tamara, et al.
Publicado: (2014)

Next-generation sequencing to dynamically detect mechanisms of resistance to ALK inhibitors in ALK-positive NSCLC patients: a case report
por: Sánchez-Herrero, Estela, et al.
Publicado: (2020)

Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma
por: Blanco, Mariola, et al.
Publicado: (2022)

New perspectives in the management of small cell lung cancer
por: Pangua, Cristina, et al.
Publicado: (2022)

Lung cancer patients with COVID-19 in Spain: GRAVID study
por: Provencio, Mariano, et al.
Publicado: (2021)

Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status
por: Fernández-Marcelo, Tamara, et al.
Publicado: (2015)

Lung Adenocarcinoma during Pregnancy: 11-Year Follow-Up
por: Acosta Rojas, Angel, et al.
Publicado: (2020)

Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world data
por: Calvo, Virginia, et al.
Publicado: (2021)

Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions
por: López-Campos, Fernando, et al.
Publicado: (2022)

CB(2) cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
por: Martínez-Martínez, Esther, et al.
Publicado: (2016)

Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel)
por: Franco, Fernando, et al.
Publicado: (2021)

SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)
por: Gumà, Josep, et al.
Publicado: (2023)

Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?
por: Fernández, Castalia, et al.
Publicado: (2022)

Recomendaciones de actuación en cirugía torácica electiva y urgente en contexto de pandemia por SARS-CoV-2 de la Sociedad Española de Cirugía Torácica (SECT)
por: Jarabo, José R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l7jma2gfa56jqb2h4h6ef9cukp